Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review

Author： Préaud Emmanuelle Largeron Nathalie

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.6, 2013-06, pp. : 763-776

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Papillomavirus and the Development of Different Cancers

Cytogenetic and Genome Research, Vol. 150, Iss. 3-4, 2017-03 ,pp. : 185-193

Karger

Access to resources Recommend Favorite

Prevention of cancers with human papillomavirus vaccination

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 66, Iss. 5, 2016-09 ,pp. : 386-386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study

By Rössler Lucia Reich Olaf Horvat Reinhard Souza Sabrina Collas Holl Katsyarina Joura Elmar A.

Wiener klinische Wochenschrift, Vol. 125, Iss. 19-20, 2013-10 ,pp. : 591-599

Springer Publishing Company

Access to resources Recommend Favorite

Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2858-2868

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the Phase II and III trials

By Harper Diane M

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 313-324

Future Medicine

Access to resources Recommend Favorite